These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34019187)

  • 1. Using Brexanolone for Postpartum Depression Must Account for Lactation.
    Rosen-Carole C; Ito S
    Matern Child Health J; 2021 Jul; 25(7):1007-1009. PubMed ID: 34019187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brexanolone Is the First Drug Specifically for Postpartum Depression.
    Fantasia HC
    Nurs Womens Health; 2019 Oct; 23(5):450-454. PubMed ID: 31445988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brexanolone for the treatment of patients with postpartum depression.
    Morrison KE; Cole AB; Thompson SM; Bale TL
    Drugs Today (Barc); 2019 Sep; 55(9):537-544. PubMed ID: 31584571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brexanolone to Treat Postpartum Depression in Adult Women.
    Cornett EM; Rando L; Labbé AM; Perkins W; Kaye AM; Kaye AD; Viswanath O; Urits I
    Psychopharmacol Bull; 2021 Mar; 51(2):115-130. PubMed ID: 34092826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brexanolone (Zulresso): Finally, an FDA-Approved Treatment for Postpartum Depression.
    Powell JG; Garland S; Preston K; Piszczatoski C
    Ann Pharmacother; 2020 Feb; 54(2):157-163. PubMed ID: 31476884
    [No Abstract]   [Full Text] [Related]  

  • 6. Brexanolone (Zulresso) for postpartum depression.
    Med Lett Drugs Ther; 2019 May; 61(1571):68-70. PubMed ID: 31169804
    [No Abstract]   [Full Text] [Related]  

  • 7. Brexanolone For Postpartum Depression: A Novel Approach and a Call for Comprehensive Postpartum Care.
    Jarman AF; MacLean JV; Barron RJ; Wightman RS; McGregor AJ
    Clin Ther; 2020 Jan; 42(1):231-235. PubMed ID: 31910998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brexanolone for postpartum depression.
    Hutcherson TC; Cieri-Hutcherson NE; Gosciak MF
    Am J Health Syst Pharm; 2020 Feb; 77(5):336-345. PubMed ID: 32073124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopregnanolone Concentrations in Breast Milk and Plasma from Healthy Volunteers Receiving Brexanolone Injection, With Population Pharmacokinetic Modeling of Potential Relative Infant Dose.
    Wald J; Henningsson A; Hanze E; Hoffmann E; Li H; Colquhoun H; Deligiannidis KM
    Clin Pharmacokinet; 2022 Sep; 61(9):1307-1319. PubMed ID: 35869362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brexanolone: A Novel Drug for the Treatment of Postpartum Depression.
    Patatanian E; Nguyen DR
    J Pharm Pract; 2022 Jun; 35(3):431-436. PubMed ID: 33302791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating postpartum depression with brexanolone.
    Burval J; Kerns R; Reed K
    Nursing; 2020 May; 50(5):48-53. PubMed ID: 32332506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brexanolone for Postpartum Depression: Clinical Evidence and Practical Considerations.
    Leader LD; O'Connell M; VandenBerg A
    Pharmacotherapy; 2019 Nov; 39(11):1105-1112. PubMed ID: 31514247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating brexanolone for the treatment of postpartum depression.
    Payne JL
    Expert Opin Pharmacother; 2021 Jun; 22(8):959-964. PubMed ID: 33645386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
    Kanes S; Colquhoun H; Gunduz-Bruce H; Raines S; Arnold R; Schacterle A; Doherty J; Epperson CN; Deligiannidis KM; Riesenberg R; Hoffmann E; Rubinow D; Jonas J; Paul S; Meltzer-Brody S
    Lancet; 2017 Jul; 390(10093):480-489. PubMed ID: 28619476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United States.
    Eldar-Lissai A; Cohen JT; Meltzer-Brody S; Gerbasi ME; Chertavian E; Hodgkins P; Bond JC; Johnson SJ
    J Manag Care Spec Pharm; 2020 May; 26(5):627-638. PubMed ID: 32191592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.
    Meltzer-Brody S; Colquhoun H; Riesenberg R; Epperson CN; Deligiannidis KM; Rubinow DR; Li H; Sankoh AJ; Clemson C; Schacterle A; Jonas J; Kanes S
    Lancet; 2018 Sep; 392(10152):1058-1070. PubMed ID: 30177236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a Hospital-based Brexanolone Program.
    Howard MM; Diaz Z; Battle CL
    J Psychiatr Pract; 2022 Sep; 28(5):404-408. PubMed ID: 36074110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brexanolone: First Global Approval.
    Scott LJ
    Drugs; 2019 May; 79(7):779-783. PubMed ID: 31006078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms Underlying Recovery From Postpartum Depression Following Brexanolone Therapy.
    Morrow AL; Balan I; Boero G
    Biol Psychiatry; 2022 Feb; 91(3):252-253. PubMed ID: 34961596
    [No Abstract]   [Full Text] [Related]  

  • 20. Brexanolone Therapy for Postpartum Depression.
    Shabbir O; Khan KS; Jawaid H
    J Pak Med Assoc; 2020 Mar; 70(3):565-566. PubMed ID: 32207453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.